Oppenheimer Upgrades Sarepta Therapeutics (SRPT) to Outperform
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $16.78 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Join SI Premium – FREE
Oppenheimer analyst Hartaj Singh upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Perform to Outperform with a price target of $180.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutics click here. For more ratings news on Sarepta Therapeutics click here.
Shares of Sarepta Therapeutics closed at $131.70 yesterday.
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) PT Lowered to $35 at Oppenheimer
- Freedom Broker Upgrades Xpel inc. (XPEL) to Buy
- Argus Upgrades eBay (EBAY) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
